Leonabio, Inc. · NASDAQ:LONA
Baselake Partners, LP reported a 5.00% stake in Leonabio, Inc. (Schedule 13G)
Event Nov 7, 2025 · Filed Nov 14, 2025
Baselake Partners, LP reported a 5.00% stake in Leonabio, Inc., 197,481 shares, as a passive investor on Nov 7, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 197,481
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baselake Partners, LP | 5.00% | 197,481 |
| Baselake Management, LLC | 5.00% | 197,481 |
| David Paolella | 5.00% | 197,481 |
Source
Related
- Leonabio, Inc.
- Baselake Partners, LP
- Leonabio, Inc. shareholders
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026
- Schedule 13D · Sermonix Pharmaceuticals, Inc. · Aug 31, 2026
- Schedule 13D/A · Perceptive Advisors LLC · Aug 25, 2026
- Schedule 13G/A · Anders Hove · Aug 20, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · May 15, 2026
- Schedule 13D/A · Perceptive Advisors LLC · May 7, 2026